NeOnc Technologies Holdings is trading at $3.24, down 6.09%, amid broad-market pressure from rising crude oil and Treasury yields. - On September 23, 2026, the Nasdaq Composite was down 0.78%, while risk appetite was soft. - No company-specific announcement, earnings release, or FDA update was identified for the date. - Biotech was gaining overall, so sector strength does not explain the decline; the move appears most consistent with broad-market pressure and stock-specific volatility.